Femme et Homme
- | Pays :
- Germany
- United States
- France
- Les 3 autres...
- | Organes : -
- | Spécialités : -
Extrait
This was a Phase II, single-arm, two-cohort multicenter clinical trial evaluating the efficacy and safety of vismodegib (GDC-0449) in patients with advanced basal cell carcinoma. All patients received vismodegib until evidence of progression, intolerable toxicities most probably attributable to vismodegib, or withdrawal from the study.
Critère d'inclusion
- Basal Cell Carcinoma